Yesterday we launched Issue 8 of our annual Biotech Review of the Year.
We covered the rise of AI through to patents related to transgenic mice, parallel imports, the Medicines and Medical Devices Bill , private equity in the sector and much more.
Whilst we tried to predict how these developments will shape 2021 and future years to come, we couldn’t avoid reporting on how the pandemic has touched every element of the global biotech market.
I hope you’ll enjoy reading the magazine as much as we enjoyed
preparing it: download the Biotech Review of the Year here.